• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    11/30/22 10:34:49 AM ET
    $AAP
    $AIM
    $ALTO
    $ANGO
    Auto & Home Supply Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AAP alert in real time by email

     

    During Wednesday's session, 107 stocks hit new 52-week lows.

    Key Facts About Today's 52-Week Lows:

    • CrowdStrike Holdings (NASDAQ:CRWD) was the largest firm on a market cap basis to set a new 52-week low.
    • WiSA Technologies (NASDAQ:WISA) was the smallest company in terms of market cap to set a new 52-week low.
    • Arcimoto (NASDAQ:FUV)'s stock traded down the lowest, falling 1807.32% to reach a new 52-week low.
    • Kronos Bio (NASDAQ:KRON)'s stock made the biggest bounce back, actually moving up 0.0% shortly after hitting a new 52-week low.

    Here are all the stocks that set new 52-week lows on Wednesday:

    • CrowdStrike Holdings (NASDAQ:CRWD) shares were down 17.67% for the day, having made a 52-week low of $108.89.
    • Zoom Video Comms (NASDAQ:ZM) shares reached a new 52-week low of $69.79 on Wednesday morning, moving up 0.21%.
    • Credit Suisse Group (NYSE:CS) stock set a new 52-week low of $3.16 on Wednesday, moving down 3.5%.
    • Advance Auto Parts (NYSE:AAP) stock achieved a new 52-week low on Wednesday morning, hitting $145.14 and moving down 1.68%.
    • SentinelOne (NYSE:S) shares moved down 11.37% on Wednesday to hit a new 52-week low of $13.27, drifting down 11.37%.
    • Lumentum Holdings (NASDAQ:LITE) shares made a new 52-week low of $52.95 on Wednesday. The stock was down 0.71% for the day.
    • Ginkgo Bioworks Holdings (NYSE:DNA) shares hit a yearly low of $1.78. The stock was down 2.7% on the session.
    • ZIM Integrated Shipping (NYSE:ZIM) stock hit a new 52-week low of $20.52. The stock was down 2.61% on the session.
    • Leonardo DRS (NASDAQ:DRS) shares reached a new 52-week low of $10.02 on Wednesday morning, moving down 6.28%.
    • Novavax (NASDAQ:NVAX) shares moved down 3.82% on Wednesday to hit a new 52-week low of $15.86, drifting down 3.82%.
    • Olo (NYSE:OLO) shares moved down 0.14% on Wednesday to hit a new 52-week low of $6.74, drifting down 0.14%.
    • MultiPlan (NYSE:MPLN) shares set a new yearly low of $1.41 this morning. The stock was down 4.7% on the session.
    • First Foundation (NASDAQ:FFWM) shares moved down 2.55% on Wednesday to hit a new 52-week low of $13.17, drifting down 2.55%.
    • iStar (NYSE:STAR) shares hit a yearly low of $7.41. The stock was down 24.04% on the session.
    • Nektar Therapeutics (NASDAQ:NKTR) shares hit a yearly low of $2.87. The stock was down 0.86% on the session.
    • Brookdale Senior Living (NYSE:BKD) shares reached a new 52-week low of $2.86 on Wednesday morning, moving down 0.68%.
    • Lilium (NASDAQ:LILM) shares moved down 2.14% on Wednesday to hit a new 52-week low of $1.35, drifting down 2.14%.
    • Solid Power (NASDAQ:SLDP) shares set a new 52-week low of $2.88. The stock traded down 29.14%.
    • Broadmark Realty Capital (NYSE:BRMK) stock set a new 52-week low of $3.92 on Wednesday, moving down 1.78%.
    • AngioDynamics (NASDAQ:ANGO) stock broke to a new 52-week low of $12.29 on Wednesday. Shares of the company traded down 0.64%.
    • CS Disco (NYSE:LAW) shares made a new 52-week low of $7.17 on Wednesday. The stock was up 0.97% for the day.
    • Xperi (NYSE:XPER) stock hit $9.72 on Wednesday morning, setting a new 52-week low for a change of down 2.85%.
    • Arcimoto (NASDAQ:FUV) stock achieved a new 52-week low on Wednesday morning, hitting $7.30 and moving up 1807.32%.
    • SI-BONE (NASDAQ:SIBN) stock broke to a new 52-week low of $11.14 on Wednesday. Shares of the company traded down 1.31%.
    • Hyzon Motors (NASDAQ:HYZN) stock dropped to a yearly low on Wednesday of $1.47. Shares traded down 0.67%.
    • Selina Hospitality (NASDAQ:SLNA) stock hit $3.38 on Wednesday morning, setting a new 52-week low for a change of down 1.42%.
    • MVB Financial (NASDAQ:MVBF) stock hit a yearly low of $23.52. The stock was down 1.13% for the day.
    • Foghorn Therapeutics (NASDAQ:FHTX) shares set a new 52-week low of $6.36. The stock traded up 1.41%.
    • GRAVITY Co (NASDAQ:GRVY) stock broke to a new 52-week low of $40.22 on Wednesday. Shares of the company traded down 1.03%.
    • Unisys (NYSE:UIS) shares reached a new 52-week low of $3.93 on Wednesday morning, moving down 0.43%.
    • Radiant Logistics (AMEX:RLGT) shares hit a yearly low of $5.31. The stock was down 0.06% on the session.
    • Sify Technologies (NASDAQ:SIFY) stock hit a new 52-week low of $1.38. The stock was down 1.77% on the session.
    • Alto Ingredients (NASDAQ:ALTO) stock achieved a new 52-week low on Wednesday morning, hitting $3.34 and moving down 2.18%.
    • Forge Global Holdings (NYSE:FRGE) shares made a new 52-week low of $1.26 on Wednesday. The stock was down 2.22% for the day.
    • Markforged Holding (NYSE:MKFG) stock set a new 52-week low of $1.12 on Wednesday, moving down 0.88%.
    • Local Bounti (NYSE:LOCL) stock hit a new 52-week low of $2.02. The stock was down 7.52% on the session.
    • Motorcar Parts of America (NASDAQ:MPAA) shares hit a yearly low of $11.07. The stock was down 2.75% on the session.
    • Berkshire Grey (NASDAQ:BGRY) stock dropped to a yearly low on Wednesday of $0.90. Shares traded down 3.22%.
    • Cango (NYSE:CANG) stock achieved a new 52-week low on Wednesday morning, hitting $1.37 and moving down 7.95%.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new yearly low of $4.50 this morning. The stock was down 1.32% on the session.
    • Summit Therapeutics (NASDAQ:SMMT) shares fell to $0.85 on Wednesday, setting a new 52-week low with a shift of down 3.36%.
    • Sema4 Holdings (NASDAQ:SMFR) stock set a new 52-week low of $0.42 on Wednesday, moving down 3.19%.
    • Republic First Bancorp (NASDAQ:FRBK) shares moved down 2.38% on Wednesday to hit a new 52-week low of $2.46, drifting down 2.38%.
    • BuzzFeed (NASDAQ:BZFD) shares made a new 52-week low of $1.06 on Wednesday. The stock was down 6.3% for the day.
    • Vaxart (NASDAQ:VXRT) stock hit a yearly low of $1.16. The stock was down 4.88% for the day.
    • Redwire (NYSE:RDW) stock hit $2.06 on Wednesday morning, setting a new 52-week low for a change of down 0.95%.
    • Inseego (NASDAQ:INSG) stock drifted down 3.15% on Wednesday morning to hit a new 52-week low of $1.23.
    • Singular Genomics Sys (NASDAQ:OMIC) stock achieved a new 52-week low on Wednesday morning, hitting $1.85 and moving down 3.14%.
    • Doma Holdings (NYSE:DOMA) stock set a new 52-week low of $0.39 on Wednesday, moving down 2.63%.
    • Grove Collaborative Hldgs (NYSE:GROV) stock drifted down 1.33% on Wednesday morning to hit a new 52-week low of $0.65.
    • Tempo Automation Holdings (NASDAQ:TMPO) shares fell to $4.30 on Wednesday, setting a new 52-week low with a shift of down 7.16%.
    • Akili (NASDAQ:AKLI) stock set a new 52-week low of $1.37 on Wednesday, moving up 4.35%.
    • USD Partners (NYSE:USDP) shares were down 0.73% for the day, having made a 52-week low of $3.23.
    • Lyra Therapeutics (NASDAQ:LYRA) stock set a new 52-week low of $3.27 on Wednesday, moving down 7.37%.
    • EyePoint Pharmaceuticals (NASDAQ:EYPT) stock achieved a new 52-week low on Wednesday morning, hitting $2.97 and moving down 4.56%.
    • Kronos Bio (NASDAQ:KRON) shares reached a new 52-week low of $1.70 on Wednesday morning, moving 0.0% (flat).
    • AppHarvest (NASDAQ:APPH) shares made a new 52-week low of $0.83 on Wednesday. The stock was down 5.99% for the day.
    • Volta (NYSE:VLTA) stock set a new 52-week low of $0.49 on Wednesday, moving down 3.52%.
    • ATI Physical Therapy (NYSE:ATIP) shares set a new yearly low of $0.39 this morning. The stock was down 7.19% on the session.
    • Eos Energy Enterprises (NASDAQ:EOSE) shares made a new 52-week low of $0.99 on Wednesday. The stock was down 1.94% for the day.
    • Science 37 Hldgs (NASDAQ:SNCE) shares reached a new 52-week low of $0.60 on Wednesday morning, moving down 4.08%.
    • Cybin (AMEX:CYBN) stock hit $0.37 on Wednesday morning, setting a new 52-week low for a change of up 2.4%.
    • Viant Technology (NASDAQ:DSP) stock set a new 52-week low of $3.62 on Wednesday, moving down 1.35%.
    • UpHealth (NYSE:UPH) shares made a new 52-week low of $0.33 on Wednesday. The stock was down 2.24% for the day.
    • Mogo (NASDAQ:MOGO) stock set a new 52-week low of $0.56 on Wednesday, moving up 1.72%.
    • IronNet (NYSE:IRNT) shares made a new 52-week low of $0.41 on Wednesday. The stock was down 3.54% for the day.
    • Apexigen (NASDAQ:APGN) stock drifted down 1.12% on Wednesday morning to hit a new 52-week low of $1.59.
    • Inuvo (AMEX:INUV) stock hit $0.29 on Wednesday morning, setting a new 52-week low for a change of down 0.2%.
    • LENSAR (NASDAQ:LNSR) stock hit a yearly low of $3.07. The stock was down 3.31% for the day.
    • MedAvail Holdings (NASDAQ:MDVL) shares moved down 2.44% on Wednesday to hit a new 52-week low of $0.44, drifting down 2.44%.
    • Boxed (NYSE:BOXD) stock dropped to a yearly low on Wednesday of $0.46. Shares traded down 1.2%.
    • Boxlight (NASDAQ:BOXL) stock hit a yearly low of $0.40. The stock was down 1.05% for the day.
    • Golden Sun Education Gr (NASDAQ:GSUN) shares reached a new 52-week low of $1.55 on Wednesday morning, moving down 4.22%.
    • Worksport (NASDAQ:WKSP) shares made a new 52-week low of $1.50 on Wednesday. The stock was up 5.86% for the day.
    • CN Energy Group (NASDAQ:CNEY) stock broke to a new 52-week low of $0.80 on Wednesday. Shares of the company traded down 32.43%.
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock hit a yearly low of $1.44. The stock was down 2.57% for the day.
    • AIM ImmunoTech (AMEX:AIM) shares set a new 52-week low of $0.40. The stock traded down 0.12%.
    • Forza X1 (NASDAQ:FRZA) shares made a new 52-week low of $1.46 on Wednesday. The stock was up 1.33% for the day.
    • IM Cannabis (NASDAQ:IMCC) shares fell to $1.89 on Wednesday, setting a new 52-week low with a shift of up 1.05%.
    • Ekso Bionics Holdings (NASDAQ:EKSO) stock hit a yearly low of $1.07. The stock was up 0.46% for the day.
    • Hallmark Financial Servs (NASDAQ:HALL) stock hit a new 52-week low of $0.63. The stock was down 1.49% on the session.
    • Imunon (NASDAQ:IMNN) shares moved down 0.71% on Wednesday to hit a new 52-week low of $1.38, drifting down 0.71%.
    • Troika Media Group (NASDAQ:TRKA) stock dropped to a yearly low on Wednesday of $0.13. Shares traded down 14.65%.
    • BIO-key Intl (NASDAQ:BKYI) shares hit a yearly low of $0.94. The stock was down 0.14% on the session.
    • Inpixon (NASDAQ:INPX) shares made a new 52-week low of $2.53 on Wednesday. The stock was up 0.19% for the day.
    • RiceBran Tech (NASDAQ:RIBT) stock set a new 52-week low of $1.11 on Wednesday, moving up 0.88%.
    • Sonnet BioTherapeutics (NASDAQ:SONN) stock dropped to a yearly low on Wednesday of $0.96. Shares traded down 2.0%.
    • Qualigen Therapeutics (NASDAQ:QLGN) shares moved down 5.0% on Wednesday to hit a new 52-week low of $1.51, drifting down 5.0%.
    • Avenue Therapeutics (NASDAQ:ATXI) stock broke to a new 52-week low of $1.24 on Wednesday. Shares of the company traded down 0.17%.
    • CNS Pharmaceuticals (NASDAQ:CNSP) shares set a new 52-week low of $3.61. The stock traded down 8.39%.
    • Code Chain New Continent (NASDAQ:CCNC) shares set a new yearly low of $2.50 this morning. The stock was down 3.8% on the session.
    • Hillstream BioPharma (NASDAQ:HILS) shares reached a new 52-week low of $0.35 on Wednesday morning, moving down 4.97%.
    • WiSA Technologies (NASDAQ:WISA) shares made a new 52-week low of $0.10 on Wednesday. The stock was down 32.89% for the day.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $AAP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAP
    $AIM
    $ALTO
    $ANGO

    CompanyDatePrice TargetRatingAnalyst
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    Foghorn Therapeutics Inc.
    $FHTX
    2/17/2026$12.00Buy
    Jefferies
    CrowdStrike Holdings Inc.
    $CRWD
    2/13/2026$446.00Hold → Buy
    HSBC Securities
    MVB Financial Corp.
    $MVBF
    2/13/2026$31.00 → $33.00Outperform
    Hovde Group
    Nektar Therapeutics
    $NKTR
    2/10/2026Mkt Perform → Outperform
    William Blair
    Zoom Communications Inc.
    $ZM
    2/5/2026$115.00Peer Perform → Outperform
    Wolfe Research
    SI-BONE Inc.
    $SIBN
    1/27/2026$21.00Buy
    TD Cowen
    Advance Auto Parts Inc.
    $AAP
    1/21/2026$55.00Neutral → Buy
    Northcoast
    More analyst ratings

    $AAP
    $AIM
    $ALTO
    $ANGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Jefferies resumed coverage on Foghorn Therapeutics with a new price target

    Jefferies resumed coverage of Foghorn Therapeutics with a rating of Buy and set a new price target of $12.00

    2/17/26 7:49:23 AM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CrowdStrike upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded CrowdStrike from Hold to Buy and set a new price target of $446.00

    2/13/26 8:22:01 AM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    $AAP
    $AIM
    $ALTO
    $ANGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Adlich Steve claimed ownership of 55,000 shares (SEC Form 3)

    3 - Redwire Corp (0001819810) (Issuer)

    2/27/26 4:44:03 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    SVP & CMO Poggenpohl Teresa covered exercise/tax liability with 9,010 shares, decreasing direct ownership by 6% to 153,508 units (SEC Form 4)

    4 - UNISYS CORP (0000746838) (Issuer)

    2/27/26 9:51:52 AM ET
    $UIS
    EDP Services
    Technology

    VP, CAO, Corporate Controller Brown David Lawrence covered exercise/tax liability with 3,507 shares, decreasing direct ownership by 7% to 46,357 units (SEC Form 4)

    4 - UNISYS CORP (0000746838) (Issuer)

    2/27/26 9:50:08 AM ET
    $UIS
    EDP Services
    Technology

    $AAP
    $AIM
    $ALTO
    $ANGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Asher Daniel bought $191,162 worth of shares (15,540 units at $12.30) (SEC Form 4)

    4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    2/20/26 4:57:37 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    Large owner Asher Daniel bought $11,520 worth of shares (1,200 units at $9.60) (SEC Form 4)

    4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    2/19/26 4:03:47 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    Director Bryan David bought $9,670 worth of shares (1,000 units at $9.67), increasing direct ownership by 1% to 72,477 units (SEC Form 4)

    4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)

    2/17/26 6:39:49 PM ET
    $MPAA
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AAP
    $AIM
    $ALTO
    $ANGO
    SEC Filings

    View All

    SEC Form 8-K filed by Lyra Therapeutics Inc.

    8-K - Lyra Therapeutics, Inc. (0001327273) (Filer)

    2/27/26 5:25:20 PM ET
    $LYRA
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by CNS Pharmaceuticals Inc.

    S-8 - CNS Pharmaceuticals, Inc. (0001729427) (Filer)

    2/27/26 5:22:40 PM ET
    $CNSP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Zoom Communications Inc.

    10-K - Zoom Communications, Inc. (0001585521) (Filer)

    2/27/26 5:18:02 PM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    $AAP
    $AIM
    $ALTO
    $ANGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mach 2 and Beyond: Aerospace Enters Its Biggest Spending Cycle

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity Insider News Commentary -- Congress approved $839 billion in Pentagon funding for fiscal 2026, $8 billion more than the Department of Defense requested, with billions earmarked for space, missile defense, and advanced aerospace systems[1]. The Pentagon's $152 billion reconciliation spending plan allocates $2.2 billion specifically to accelerate hypersonic defense systems and $5.6 billion for space-based interceptors[2]. Companies positioned across aerospace testing, defense technology, and space infrastructure include Starfighters Space (NYSE-A: FJET), Kratos Defense (NASDAQ:KTOS), V2X (NYSE:VVX), Redwire (NYS

    2/27/26 11:24:00 AM ET
    $FJET
    $KTOS
    $LUNR
    Air Freight/Delivery Services
    Consumer Discretionary
    Military/Government/Technical
    Industrials

    AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering

    OCALA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) – AIM ImmunoTech Inc. ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic cancer – a lethal and unmet global health problem – today announced updated terms for its previously announced rights offering (the "Rights Offering"). Each subscription right now entitles holders to purchase one unit (the "Units"), each Unit consisting of one share of the Company's Series G Convertible Preferred Stock (the "Preferred Stock"), and 2,000 Class G Common Stock Purchase Warrants to purchase the Compa

    2/27/26 9:00:00 AM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Summit Therapeutics to Present at Upcoming Investor Conferences

    Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced that it will participate in three upcoming investor conferences during March of this year. Members of the Summit leadership team will participate in individual investor meetings along with some fireside chats at the following conferences: TD Cowen's 46th Annual Health Care Conference in Boston on Monday, March 2, 2026 Fireside chat 2:30pm ET Jefferies Conference in Miami on Tuesday, March 10, 2026 Investor meetings only Citizens Life Sciences Conference in Miami on Wednesday, March 11, 2026 Fireside chat 2:15pm ET The fireside chats will be available live on our website: www.

    2/26/26 6:45:00 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $AIM
    $ALTO
    $ANGO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AAP
    $AIM
    $ALTO
    $ANGO
    Leadership Updates

    Live Leadership Updates

    View All

    Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that Ryan Maynard will join the company as Chief Financial Officer (CFO) on February 23, 2026. Mr. Maynard joins Foghorn with over 25 years of executive experience driving financial strategy, capital markets execution, and operational performance across public and private biopharmaceutical companies. "I am delighted to welcome Ryan to Foghorn as our new CFO as we continue to advance our first-in-class pipeline," said Adrian Gottschalk, Pres

    2/23/26 7:00:00 AM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MVB Financial Names Dr. Kelly Nelson Chairman of the Board of Directors; Appoints Adam Famularo New Director

    The Board of Directors of MVB Financial Corp. ("MVBF" or "MVB Financial") (NASDAQ:MVBF), today announced that Dr. Kelly R. Nelson has been named Chairman of the Board and announced the appointment of Adam Famularo as a Member of the Board, effective February 17, 2026. Dr. Nelson Assumes Chairman Role Dr. Nelson, who has been a member of the Board since 2004, replaces retiring Chairman W. Marston "Marty" Becker. "Dr. Nelson brings a combination of medical expertise, business acumen and deep community commitment to his new role as Chairman," said Larry F. Mazza, CEO and President, MVB Financial. "His experience makes him uniquely suited for this leadership role. Dr. Nelson previously ch

    2/18/26 4:30:00 PM ET
    $MVBF
    Major Banks
    Finance

    EyePoint Appoints Michael Campbell as Chief Commercial Officer

    – Seasoned commercial executive with over 30 years of leadership in retinal disease across biotech and large pharma –– Brings established track record of successful product launches and oversight of prominent ophthalmology franchises, including Lucentis® and Xiidra® – WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Michael Campbell has been appointed Chief Commercial Officer. Mr. Campbell, an experienced commercial leader with a proven track record of successful product launches and oversight of

    2/18/26 7:00:00 AM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AAP
    $AIM
    $ALTO
    $ANGO
    Financials

    Live finance-specific insights

    View All

    Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets

    SAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2025 on Thursday, March 12, 2026, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time. This press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar web

    2/26/26 6:00:00 PM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    Ginkgo provides an update on its fourth quarter financial resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA, ", Ginkgo", )) today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on the third quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com. Fourth Quarter 2025 Financial ResultsFourth quarter 2025 Total revenue of $33 million compared to $44 million in the comparable prior year pe

    2/26/26 4:26:00 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Inuvo to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on Thursday, March 5th at 4:15 P.M. ET

    LITTLE ROCK, Ark., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE:INUV), a leader in artificial intelligence-driven advertising technology, will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, March 5, 2026. The Company will host a conference call at 4:15 p.m. Eastern Time that same day to discuss the results and provide a business update. Conference Call Details: Date: Thursday, March 5, 2026Time: 4:15 p.m. Eastern Time Toll-free Dial-in Number: 1-800-717-1738International Dial-in Number: 1-646-307-1865Conference ID: 1145199Webcast Link: HERE A telephone replay will be available through Thursday, March 19,

    2/26/26 8:15:00 AM ET
    $INUV
    Advertising
    Consumer Discretionary

    $AAP
    $AIM
    $ALTO
    $ANGO
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Stock Movement: Insider Purchase at Motorcar Parts of America Inc. on Jun 17

    Recently, on June 17, 2024, Director Bison Capital Partners Vi, L.P. made a significant move by purchasing $874,000 worth of Motorcar Parts of America Inc. shares. This purchase consisted of 150,000 units at a price of $5.83 per share, marking a substantial increase in direct ownership by 150% to 250,000 units as reported in SEC Form 4. The timing and scale of this insider purchase are noteworthy as it indicates a strong belief in the company's future prospects. Examining the series of insider transactions involving Motorcar Parts of America Inc. insiders, there seem to be interesting patterns emerging. In particular, Ferguson Joseph Edwin, Rankin Jamy P., and Gay Philip all converted optio

    6/18/24 10:09:31 PM ET
    $MPAA
    Auto Parts:O.E.M.
    Consumer Discretionary

    Stock Movement: Insider Purchase at Motorcar Parts of America Inc. on Jun 18

    On June 18, 2024, Director Bison Capital Partners Vi, L.P. bought $116,319 worth of shares (20,300 units at $5.73), increasing their direct ownership by 8% to 270,300 units, as reported in SEC Form 4. This insider purchase indicates a strong show of confidence in the future prospects of Motorcar Parts of America Inc. When analyzing this transaction alongside other recent activities by company insiders, some interesting patterns emerge. Gay Philip converted options into 6,596 shares, increasing his direct ownership by 18% to 42,576 units back on November 16, 2023. This move indicated a bullish sentiment from an insider perspective. However, not all insider activities were positive. Borneo R

    6/18/24 10:06:20 PM ET
    $MPAA
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AAP
    $AIM
    $ALTO
    $ANGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by AIM ImmunoTech Inc.

    SC 13D/A - AIM ImmunoTech Inc. (0000946644) (Subject)

    12/17/24 4:11:23 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous